Blueshift Asset Management, LLC Amicus Therapeutics, Inc. Transaction History

Blueshift Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$9.82 - $12.44 $881,502 - $1.12 Million	-89,766 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$8.74 - $11.84 $601,862 - $815,337	68,863 Added 329.44%	89,766 $857,000
Q2 2021 Aug 13, 2021	BUY	$8.71 - $10.72 $182,065 - $224,080	20,903 New	20,903 $202,000
Q1 2021 May 06, 2021	SELL	$9.2 - $23.86 $165,894 - $430,243	-18,032 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$13.47 - $24.89 $242,891 - $448,816	18,032 New	18,032 $416,000
Q1 2020 May 14, 2020	SELL	$6.63 - $11.16 $150,613 - $253,521	-22,717 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $78,831 - $113,294	10,539 Added 86.54%	22,717 $221,000
Q3 2019 Nov 12, 2019	BUY	$8.02 - $13.25 $97,667 - $161,358	12,178 New	12,178 $98,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.